# Faecal Bacteriotherapy for Ulcerative Colitis

> **NCT03104036** · PHASE2 · COMPLETED · sponsor: **Institute for Clinical and Experimental Medicine** · enrollment: 61 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **OTHER:** Faecal bacterial transplantation
- **DRUG:** Mesalazine 4G Enema

## Key facts

- **NCT ID:** NCT03104036
- **Lead sponsor:** Institute for Clinical and Experimental Medicine
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-19
- **Primary completion:** 2021-01-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2021-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03104036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03104036, "Faecal Bacteriotherapy for Ulcerative Colitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03104036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*